Teaming up to fight obesity
Today’s Orlando Sentinel features a unique initiative that Florida Hospital (a Sanford-Burnham partner) has created to fight childhood obesity. Called Healthy 100 Kids, the program unites a...
View ArticleWelcome to “MeD Camp”
Scientists at Sanford-Burnham’s Lake Nona campus recently hosted 26 high school students from surrounding Orlando schools during the second annual Medical Summer Camp (MeD Camp), a joint project with...
View ArticleFlorida’s Bioscience Leaders Convene
Drs. Stephen Gardell and Stephen Vasile represented Sanford-Burnham Medical Research Institute earlier this week at the 13th annual BioFloridaConference. The conference is the state’s largest gathering...
View ArticleNew home for translational research
Dr. Steven Smith, executive director of the Florida Hospital-Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI), took control of a backhoe to help demolish an old...
View ArticleCollaboration with Takeda seeks to translate research into treatments
Sanford-Burnham, Florida Hospital and Takeda Pharmaceutical have formed a collaboration to investigate new therapies for obesity, a growing worldwide health problem. The partnership leverages the three...
View ArticleA different kind of dorm room
Obesity negatively affects the entire body – no organ system is left untouched. It increases a person’s risk of type 2 diabetes, high blood pressure, depression, certain cancers and many other...
View ArticleBuilding translational research
The Translational Research Institute for Metabolism and Diabetes (TRI), a collaboration between Sanford-Burnham and Florida Hospital, is one step closer to opening its research facility. The 54,000...
View ArticleObesity is not one condition: an interview with Dr. Steven Smith
Dr. Steven Smith is the scientific director of the Translational Research Institute for Metabolism and Diabetes, a collaboration between Sanford-Burnham and Florida Hospital. In a special presentation...
View ArticleIntroducing the Partnership for Personalized Medicine in Florida
Sanford-Burnham, Moffitt Cancer Center, and Florida Hospital announced today that they will collaborate to create a Personalized Medicine Partnership of Florida (PMP Florida). The partnership will...
View ArticleTranslational Research Institute establishes new research paradigm for...
Florida Hospital and Sanford-Burnham today celebrate the opening of the Florida Hospital – Sanford-Burnham Translational Research Institute for Metabolism and Diabetes’ (TRI) new state-of-the-art...
View ArticleA “twisted” grand opening ceremony
“My goal is to cure diabetes,” Steven Smith, M.D., scientific director of the Florida Hospital – Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI), said boldly at the...
View ArticleTop 10 most-read blog posts of 2012: #9
Translational Research Institute establishes new research paradigm for metabolic diseases Originally published March 27, 2012 Florida Hospital and Sanford-Burnham today celebrate the opening of the...
View ArticleHow belly fat differs from thigh fat—and why it matters
Researchers discover that the genes active in a person’s belly fat are significantly different from those in his or her thigh fat, a finding that could shift the way we approach unwanted belly fat—from...
View ArticlePartnering with Asia’s largest pharmaceutical company to find obesity treatments
We held a special signing ceremony today at our Lake Nona, Orlando, campus to renew our research agreement with Florida Hospital and Takeda Pharmaceutical Company Limited. The renewal extends our...
View ArticleJoining forces with the International Prostate Cancer Foundation to develop...
During a ceremony at Sanford-Burnham at Lake Nona on May 10, the International Prostate Cancer Foundation (IPCF) awarded Ranjan Perera, Ph.D., scientific director of analytical genomics and...
View ArticleLong-neglected molecules show promise for cancer detection and treatment
This post was written by our guest blogger Janelle Weaver, Ph.D. Eukaryotic cells consist of thousands of RNA molecules that do not get translated into proteins. These noncoding RNAs can be classified...
View ArticleNew molecular markers for prostate cancer identified
A team of scientists led by Sanford-Burnham’s Ranjan J. Perera, Ph.D., has identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients, but not in...
View ArticleSanford-Burnham’s Steven R. Smith leads clinical study on new weight-loss...
In a new pilot study led by principal investigator Steven R. Smith, M.D., the weight-loss drug lorcaserin (LOR), was tested in combination with the drug phentermine (phen) to compare safety and weight...
View ArticleExercise following bariatric surgery provides health benefits
A new study by researchers at the Florida Hospital – Sanford-Burnham Translational Research Institute for Metabolism and Diabetes (TRI-MD) in Orlando, Fla., shows that patients who moderately exercise...
View ArticleResearchers find new method to halt the advance of liver cancer
Liver cancer is the third leading cause of cancer-related deaths worldwide. New research indicates that blocking the activity of the lymphotoxin-beta receptor may improve the outcome of for patients...
View Article
More Pages to Explore .....